Email Not Verified

Action Required

Please go to your profile settings and make sure your email is verified before applying for account verification.

Please refer to the documentation here.

Confirm Account Verification

Final Step

Please make sure you have filled in all the required details.

We need these details to verify your account. Once you click Yes, we will send an account activation request to our team.

Please refer to the documentation here.
Back to Top
Go Back
Journal Photo for Clinical Proteomics
Peer reviewed only Open Access

Clinical Proteomics (CP)

Publisher : Springer Nature
Protein and peptide profiling in clinical samples Biomarker discovery and validation Molecular mechanisms of human diseases
Claim Your Journal Get PRC Visit Website
e-ISSN 1559-0275
p-ISSN 1542-6416
Issue Frequency Quarterly
Est. Year 2004
Mobile 4402031922009
Language English
APC YES
Email journalsubmissions@springernature.com

Journal Descriptions

Clinical Proteomics is an international peer-reviewed open access journal published by BioMed Central, part of Springer Nature. Established in 2004, the journal focuses on advancing research in translational and clinical proteomics, emphasizing the application of protein and peptide analysis in clinical and biomedical research. The journal publishes original research articles, reviews, and methodological studies that explore protein expression profiling, biomarker discovery, and the molecular mechanisms of diseases. A strong emphasis is placed on the use of proteomic technologies such as mass spectrometry, protein microarrays, and bioinformatics tools to support precision medicine and personalized healthcare. Clinical Proteomics serves as a platform for studies that bridge laboratory research and clinical applications, including diagnostic marker identification, therapeutic target discovery, and disease mechanism analysis. It is widely used by researchers in biochemistry, molecular medicine, oncology, and systems biology. The journal is indexed in major databases such as Scopus, PubMed, Web of Science, and EMBASE, ensuring strong visibility in the scientific community. With an impact factor around 3.3 and a rigorous peer-review process, it is considered a reputable Q2 journal in the field of proteomics and biomedical sciences. Under the editorial leadership of Prof. Daniel W. Chan, it continues to support high-quality research in clinical applications of proteomics.

Clinical Proteomics (CP) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Protein and peptide profiling in clinical samples, Biomarker discovery and validation, Molecular mechanisms of human diseases, Precision and personalized medicine, Mass spectrometry–based clinical analysis, Bioinformatics in proteomics, Diagnostic and therapeutic protein markers, Application of proteomics in cancer and disease research, mass spectrometry, protein microarrays, bioinformatics tools to support precision medicine and personalized healthcare , Online or Print , Quarterly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1542-6416, E-ISSN: 1559-0275, Established: 2004,
  • Does Not Provide Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE